{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-098564","form_type":"8-K","ticker":"ABBV","cik":"0001551152","company_name":"AbbVie Inc.","filed_at":"2024-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.480081+00:00","generated_at":"2026-05-31T05:38:17.495474+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"AbbVie amends bylaws, deletes section 2.13(D)(iv) amid stockholder class action","bullets":["Board approved Third Amended and Restated By-laws effective September 6, 2024.","Amendments update registered agent address and delete Section 2.13(D)(iv) in its entirety.","Company is defendant in a stockholder class action challenging Section 2.13(D)(iv).","Company believes provision lawful but no longer of practical value; deletion avoids defending it."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-098564","json":"https://secwatch.observer/filing/0001104659-24-098564.json","markdown":"https://secwatch.observer/filing/0001104659-24-098564.md","text":"https://secwatch.observer/filing/0001104659-24-098564.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/0001104659-24-098564-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/tm2423380d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:38:17.495474+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}